Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Khan Najat, holds the title of CEO and President at RECURSION PHARMACEUTICALS, INC..
On 2026-11-16, the insider transacted 85,815 shares.The shares were transacted at a weighted average price of $3.19 per share, resulting in a total market-relevant value of $273K.
Khan Najat (CEO and President) had withheld for taxes $273K of $RXRX
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.